MBII Marrone Bio Innovations Inc

Vive Crop Protection and Marrone Bio Innovations join forces to bring next-generation crop protection solutions to growers

Vive Crop Protection and Marrone Bio Innovations join forces to bring next-generation crop protection solutions to growers

TORONTO and DAVIS, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, and Vive Crop Protection, a leader in Precision Chemistry solutions and owner of the patented Allosperse® technology, announced an agreement that will provide a suite of ground-breaking products for U.S. growers that combine a leading biological with proven conventional chemistry utilizing the unique Allosperse Delivery System.

The first product to come from this joint effort will be AZterknot™ FC, a fungicide for broad crop use marketed by Vive Crop Protection. It fuses the plant health benefits of two actives: Reynoutria extract, the active ingredient in biological market-leader Regalia®, and the disease-fighting power of azoxystrobin, the active ingredient in AZteroid® FC 3.3.

AZterknot FC will also contain Vive’s Allosperse Delivery System technology, which provides superior handling characteristics including compatibility with in-furrow, pop-up and foliar liquid fertilizers. Pending EPA registration approval, the product will be approved for foliar and in-furrow application on all major crops in the U.S. (excluding California).

Dan Bihlmeyer, vice president of sales and marketing with Vive Crop Protection says, “The collaboration with MBI allows us to bring growers the best of three approaches to crop protection: chemistry, biologicals and nanotechnology. With AZterknot FC, growers will have access to the combined power of a leading biological and of a proven fungicide chemistry. Research has shown that the two actives, in combination with the Allosperse Delivery System, work together to control disease, improve plant health, and increase yield.”

MBI will also market a version of the product to specialty crop growers when regulatory approval is granted. Regalia is one of the most used biologicals in the specialty crop market and the combination with azoxystrobin and the Allosperse technology will provide specialty crop growers with the convenience of a single product that delivers enhanced performance and improved yield in a highly compatible formulation.

“Our partnership with Vive is an example of how MBI has focused on growth by creating innovative and integrated crop management solutions for growers of a wide range of crops,” said Kevin Hammill, chief commercial officer for Marrone Bio Innovations. “These next-generation BioUnite products will not only give U.S. growers access to effective crop protection technology, but it will allow them to better manage their crops by harnessing the power of biologicals with the performance of chemistry.”

Regulatory approval for AZterknot FC is expected in mid-2021 and will be available through distributor and retail commercial channels in the U.S.

About Vive Crop Protection

Vive creates Precision Chemistry to expand the horizons of Precision Ag. Using the Allosperse® Delivery System, Vive greatly improves the targeting and performance of chemical and biological active ingredients, helping growers achieve real results.

For more information, visit .

About Marrone Bio Innovations

Marrone Bio Innovations Inc. (NASDAQ: MBII) is a growth-oriented company leading the movement to a more sustainable world through the discovery, development and sale of innovative biological products for crop protection, plant health and waterway systems treatment that help customers operate more sustainably while increasing their return on investment. MBI has screened over 18,000 microorganisms and 350 plant extracts, leveraging its in-depth knowledge of plant and soil microbiomes enhanced by advanced molecular technologies and natural product chemistry to rapidly develop seven product lines. Supported by a robust portfolio of over 400 issued and pending patents, MBI’s currently available commercial products are Regalia®, Stargus®, Grandevo®, Venerate®, Majestene®, Haven®, Pacesetter™, Zelto® Jet Oxide® and Jet Ag® and Zequanox®, with a next-generation insecticide-nematicide, a breakthrough bioherbicide and a biofumigant in the Company’s product pipeline. MBI’s Pro Farm Finland-based subsidiary employs a proprietary technology derived from wood waste to stimulate plant growth and improve plant health, resulting in improved yields and crop quality. Products include UBP™ 110, Foramin®, UBP™ Seed Treatment, Foramin® ST.

Learn more about Marrone Bio Innovations at . We also use our investor relations website, , as well as our corporate Twitter account, @Marronebio, as means of disclosing material non-public information, and encourage our investors and others to monitor and review the information we make public in these locations. Follow us on social media: ,  and .

Marrone Bio Innovations Forward Looking Statements

This press release contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding strategy, future operations and plans, including assumptions underlying such statements, are forward-looking statements, and should not be relied upon as representing MBI’s views as of any subsequent date. Such forward-looking statements are based on information available to the Company as of the date of this release and involve a number of risks and uncertainties, some beyond the Company’s control, that could cause actual results to differ materially from those anticipated by these forward-looking statements, including, the potential of Regalia pre-mixture with Vive, weather, the novel coronavirus COVID-19, regulatory and other factors affecting demand for the MBI’s products, any difficulty in marketing MBI’s products in its target markets, competition in the market for pest management products, lack of understanding of bio-based pest management products by customers and growers. Additional information that could lead to material changes in MBI’s performance is contained in its filings with the SEC. MBI is under no obligation to, and expressly disclaims any responsibility to, update or alter forward-looking statements contained in this release, whether as a result of current information, future events or otherwise.

Vive Crop Protection Contact:

Dan Bihlmeyer, VP Sales and Marketing



1-810-852-2828

Marrone Bio Innovations Contact:

Kevin Hammill, Chief Commercial Officer



1-530-750-2800

Investor Relations Contact:

Greg Falesnik or Luke Zimmerman

MZ Group – MZ North America

Phone: 949-385-6449

AZterknotTM, AZteroid® and Allosperse® are trademarks of Vive Crop Protection Inc.

Regalia® and all other marks are trademarks of Marrone Bio Innovations

EN
06/08/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Marrone Bio Innovations Inc

 PRESS RELEASE

Marrone Bio Innovations, Inc. Shareholders Approve Merger Agreement wi...

Marrone Bio Innovations, Inc. Shareholders Approve Merger Agreement with Bioceres Crop Solutions Corp. RALEIGH, N.C., July 11, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI) announced that during a special shareholder meeting held on July 8, 2022, its shareholders approved a proposal to adopt the previously announced Agreement and Plan of Merger (Merger Agreement), dated as of March 16, 2022, by and among Bioceres Crop Solutions Corp. (BIOX), BCS Merger Sub, Inc., and MBI, pursuant to which MBI will be acquired by BIOX. At the special meeting, MBI’s stockholde...

 PRESS RELEASE

Marrone Bio Innovations, Inc. Reports First-Quarter 2022 Financial Res...

Marrone Bio Innovations, Inc. Reports First-Quarter 2022 Financial Results RALEIGH, N.C., May 11, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, has provided its financial results for the first quarter ended March 31, 2022. Key results include: Higher sales of row crop products in the first quarter were somewhat offset by lower sales into specialty crop markets, which were affected by adverse weather conditions. Based on the strength of current orders, revenues in the first half are expected to increase in the ...

 PRESS RELEASE

Marrone Bio Innovations to Report First Quarter 2022 Results on Wednes...

Marrone Bio Innovations to Report First Quarter 2022 Results on Wednesday, May 11 at 4:30 p.m. Eastern Time RALEIGH, N.C., April 27, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, will release financial results for the first quarter ended March 31, 2022, after market close on Wednesday, May 11, 2022. Management will host an investor conference call at 4:30 p.m. ET to discuss Marrone Bio Innovations’ first quarter financial re...

 PRESS RELEASE

Marrone Bio Innovations, Inc. Reports Fourth-Quarter and Full-Year 202...

Marrone Bio Innovations, Inc. Reports Fourth-Quarter and Full-Year 2021 Financial Results RALEIGH, N.C., March 28, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, has provided its financial results for the fourth quarter and full year ended December 31, 2021. Key results include: Full year revenues rose 15.5%, with a 40.2% increase in the fourth quarter.Gross profit grew 19.1% and 31.5% for the full year and fourth quarter, respectively, with margins exceeding 59% in both periods.For the full year, net loss was ...

 PRESS RELEASE

Marrone Bio Expands Biological Seed Treatment Collaboration for Row Cr...

Marrone Bio Expands Biological Seed Treatment Collaboration for Row Crops Company poised for continued growth in a $6+ billion market¹ RALEIGH, N.C., March 24, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: MBII), has signed an agreement with Corteva Agriscience (NYSE: CTVA) that expands the opportunity for MBI technologies to be used on seeds sold by Corteva for row crops globally. Marrone Bio currently provides seed treatment solutions to Corteva for use throughout Europe. MBI introduced biological seed treatments as a sustainable alternative to control yield-robbing pests in the United States i...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch